Engineers Gate Manager LP Gossamer Bio, Inc. Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.98 - $1.53 $69,467 - $108,454	70,885 Added 138.84%	121,939 $146,000
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $185,082 - $562,958	-192,794 Reduced 79.06%	51,054 $64,000
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $424,295 - $3.14 Million	243,848 New	243,848 $529,000
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $89,972 - $147,315	-10,840 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $122,492 - $159,890	10,840 New	10,840 $135,000
Q3 2019 Nov 14, 2019	SELL	$16.02 - $22.47 $385,953 - $541,347	-24,092 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$16.12 - $22.89 $388,363 - $551,465	24,092 New	24,092 $534,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.